Fox News has apparently spent only about 20 minutes covering spending cuts to the National Institutes of Health since ...

- Elumina is a Phase 2, multicenter, double-blind, randomized, placebo-controlled, clinical trial to assess the efficacy, ...

Endo, Inc. (OTCQX: NDOI) revealed new insights from a post hoc data analysis of its Phase 3 clinical trial of XIAFLEX® ...

New data from the MK-8591A-051 and MK-8591A-052 trials, both investigating the efficacy and safety of 100-mg doravirine and 0.25-mg islatravir as a once-daily 2-drug regimen for virologically ...

In the third part of his video interview with Pharma Commerce Editor Nicholas Saraceno, Jason C. Foster, CEO of Ori Biotech, ...

Crizanlizumab (Adakveo) failed to outperform placebo in patients with sickle cell disease, the phase III STAND trial showed.

Van Lanschot Kempen Life Sciences Conference MADRID, Spain and CAMBRIDGE, Mass., March 14, 2025 (GLOBE NEWSWIRE) -- Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a clinical-stage ...

Dianthus Therapeutics, Inc. (Nasdaq: DNTH), a clinical-stage biotechnology company dedicated to advancing the next ...

The double-blind, placebo-controlled trial aims to evaluate the drug’s pharmacodynamics, tolerability, pharmacokinetics and safety in healthy individuals. It will also measure key pharmacodynamic ...

Skin cancer is the most common cancer in the United States and a significant health issue, with millions of non-melanoma ...

Editor's note: Season 8 spoilers ahead! The curtain falls on yet another season of Netflix's "Love is Blind" and of the five couples who got engaged in Season 8's pods sight unseen, only one made ...